Genetic testing may be valuable in treating colorectal cancer
Monday, July 27, 2009 - 10:42
in Health & Medicine
NEW YORK (July 27, 2009) -- For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival.